141 related articles for article (PubMed ID: 20881555)
1. Patient age and vasospasm after subarachnoid hemorrhage.
Ryttlefors M; Enblad P; Ronne-Engström E; Persson L; Ilodigwe D; Macdonald RL
Neurosurgery; 2010 Oct; 67(4):911-7. PubMed ID: 20881555
[TBL] [Abstract][Full Text] [Related]
2. Clazosentan: prevention of cerebral vasospasm and the potential to overcome infarction.
Beck J; Raabe A
Acta Neurochir Suppl; 2011; 110(Pt 2):147-50. PubMed ID: 21125461
[TBL] [Abstract][Full Text] [Related]
3. Method of aneurysm treatment does not affect clot clearance after aneurysmal subarachnoid hemorrhage.
Ibrahim GM; Vachhrajani S; Ilodigwe D; Kassell NF; Mayer SA; Ruefenacht D; Schmiedek P; Weidauer S; Pasqualin A; Macdonald RL
Neurosurgery; 2012 Jan; 70(1):102-9; discussion 109. PubMed ID: 21788917
[TBL] [Abstract][Full Text] [Related]
4. The effect of endothelin receptor antagonists on vasospasm following aneurysmal subarachnoid hemorrhage.
Komotar RJ; Starke RM; Connolly ES
Neurosurgery; 2011 Dec; 69(6):N13-4. PubMed ID: 22067343
[No Abstract] [Full Text] [Related]
5. Effects of the selective endothelin A (ET(A)) receptor antagonist Clazosentan on cerebral perfusion and cerebral oxygenation following severe subarachnoid hemorrhage - preliminary results from a randomized clinical series.
Barth M; Capelle HH; Münch E; Thomé C; Fiedler F; Schmiedek P; Vajkoczy P
Acta Neurochir (Wien); 2007; 149(9):911-8; discussion 918. PubMed ID: 17700991
[TBL] [Abstract][Full Text] [Related]
6. Randomised trial of clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid hemorrhage undergoing surgical clipping (CONSCIOUS-2).
Macdonald RL; Higashida RT; Keller E; Mayer SA; Molyneux A; Raabe A; Vajkoczy P; Wanke I; Bach D; Frey A; Marr A; Roux S; Kassell N
Acta Neurochir Suppl; 2013; 115():27-31. PubMed ID: 22890639
[TBL] [Abstract][Full Text] [Related]
7. Thick and Diffuse Subarachnoid Blood as a Treatment Effect Modifier of Clazosentan After Subarachnoid Hemorrhage.
Mayer SA; Aldrich EF; Bruder N; Hmissi A; Macdonald RL; Viarasilpa T; Marr A; Roux S; Higashida RT
Stroke; 2019 Oct; 50(10):2738-2744. PubMed ID: 31394993
[TBL] [Abstract][Full Text] [Related]
8. Electrocardiographic changes predict angiographic vasospasm after aneurysmal subarachnoid hemorrhage.
Ibrahim GM; Macdonald RL
Stroke; 2012 Aug; 43(8):2102-7. PubMed ID: 22678087
[TBL] [Abstract][Full Text] [Related]
9. Preventive Effect of Clazosentan against Cerebral Vasospasm after Clipping Surgery for Aneurysmal Subarachnoid Hemorrhage in Japanese and Korean Patients.
Fujimura M; Joo JY; Kim JS; Hatta M; Yokoyama Y; Tominaga T
Cerebrovasc Dis; 2017; 44(1-2):59-67. PubMed ID: 28463833
[TBL] [Abstract][Full Text] [Related]
10. Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial.
Macdonald RL; Kassell NF; Mayer S; Ruefenacht D; Schmiedek P; Weidauer S; Frey A; Roux S; Pasqualin A;
Stroke; 2008 Nov; 39(11):3015-21. PubMed ID: 18688013
[TBL] [Abstract][Full Text] [Related]
11. Dissociation of vasospasm-related morbidity and outcomes in patients with aneurysmal subarachnoid hemorrhage treated with clazosentan: a meta-analysis of randomized controlled trials.
Shen J; Pan JW; Fan ZX; Xiong XX; Zhan RY
J Neurosurg; 2013 Jul; 119(1):180-9. PubMed ID: 23641823
[TBL] [Abstract][Full Text] [Related]
12. Different effects of clazosentan on consequences of subarachnoid hemorrhage in rats.
Chen G; Tariq A; Ai J; Sabri M; Jeon HJ; Tang EJ; Lakovic K; Wan H; Macdonald RL
Brain Res; 2011 May; 1392():132-9. PubMed ID: 21466789
[TBL] [Abstract][Full Text] [Related]
13. An Update on the Efficacy and Safety Profile of Clazosentan in Cerebral Vasospasm After Aneurysmal Subarachnoid Hemorrhage: A Meta-Analysis.
Song J; Xue YQ; Wang YJ; Xu P; Sun DK; Chen W
World Neurosurg; 2019 Mar; 123():e235-e244. PubMed ID: 30496924
[TBL] [Abstract][Full Text] [Related]
14. [Protective measures against cerebral ischemia following subarachnoid hemorrhage: Part 2].
Verger Bennasar AM; Romero Kräuchi O
Rev Esp Anestesiol Reanim; 2011 Apr; 58(4):236-42. PubMed ID: 21608280
[No Abstract] [Full Text] [Related]
15. A numerical approach to patient-specific cerebral vasospasm research.
Ho H; Zhang C; Xie X; Hunter P
Acta Neurochir Suppl; 2011; 110(Pt 2):157-60. PubMed ID: 21125463
[TBL] [Abstract][Full Text] [Related]
16. Clazosentan (AXV-034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: results of a randomized, double-blind, placebo-controlled, multicenter phase IIa study.
Vajkoczy P; Meyer B; Weidauer S; Raabe A; Thome C; Ringel F; Breu V; Schmiedek P
J Neurosurg; 2005 Jul; 103(1):9-17. PubMed ID: 16121967
[TBL] [Abstract][Full Text] [Related]
17. Delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: is angiographic vasospasm an epiphenomenon?
Vergouwen MD; Vermeulen M; Roos YB
Stroke; 2009 Feb; 40(2):e39; author reply e40. PubMed ID: 19074477
[No Abstract] [Full Text] [Related]
18. Impact of systemic inflammatory response syndrome on vasospasm, cerebral infarction, and outcome after subarachnoid hemorrhage: exploratory analysis of CONSCIOUS-1 database.
Tam AK; Ilodigwe D; Mocco J; Mayer S; Kassell N; Ruefenacht D; Schmiedek P; Weidauer S; Pasqualin A; Macdonald RL
Neurocrit Care; 2010 Oct; 13(2):182-9. PubMed ID: 20593247
[TBL] [Abstract][Full Text] [Related]
19. Is vasospasm actually bad for you?
Crowley RW; Macdonald RL
World Neurosurg; 2011; 76(1-2):6. PubMed ID: 21839927
[No Abstract] [Full Text] [Related]
20. Admission angiographic cerebral circulation time may predict subsequent angiographic vasospasm after aneurysmal subarachnoid hemorrhage.
Udoetuk JD; Stiefel MF; Hurst RW; Weigele JB; LeRoux PD
Neurosurgery; 2007 Dec; 61(6):1152-9; discussion 1159-61. PubMed ID: 18162893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
